| N | % | |
---|---|---|---|
Total sample | Â | 1010 | Â |
Sex | Male | 561 | 56 |
Female | 449 | 44 | |
Age group | 18–24 years | 156 | 15 |
25–34 years | 243 | 24 | |
35–44 years | 231 | 23 | |
45–54 years | 238 | 24 | |
55–65 years | 142 | 14 | |
Diagnosis | Psychiatric Comorbidity | 343 | 33 |
Schizophrenia only | 233 | 23 | |
Bipolar disorder only | 145 | 14 | |
Depressive disorder only | 159 | 16 | |
Other | 130 | 14 | |
Psychotropic Medication | Antipsychotic | 562 | 56 |
Antidepressant | 477 | 47 | |
Mood-stabiliser | 290 | 29 | |
Cognitive ability | Normal (> = 26) | 648 | 65 |
impaired (< 26) | 354 | 35 | |
Treatment setting | Inpatient | 537 | 53 |
Outpatient | 469 | 47 | |
Smoking status | Smoker | 611 | 60 |
Non-smoker | 399 | 40 | |
Body mass index (BMI)(kg/m2) | Underweight (< 18.5) | 32 | 4 |
Desired (18.5–24.99) | 305 | 36 | |
Overweight (25–29.99) | 267 | 31 | |
Obese I (30–34.99) | 171 | 20 | |
Obese II (35–39.99) | 50 | 6 | |
Obese III (40–44.99) | 27 | 3 | |
Region | Europe | 507 | 50 |
Asia | 249 | 25 | |
Oceania | 144 | 14 | |
Americas | 100 | 10 | |
Africa | 10 | 1 | |
High income | 777 | 77 | |
Country income status | Other (lower-upper middle income) | 233 | 23 |